Wall Street Analyst Thinks Pfizer Stock Could Soar 38% This Week
A single wall street analyst thinks Pfizer's stock could spark a meaningful rally. Learn the catalysts, risks, and ho...
An accessible primer on stock index levels, detailing what they represent, how they’re calculated, and why they matter for portfolio assessment.
20,792 articlesA single wall street analyst thinks Pfizer's stock could spark a meaningful rally. Learn the catalysts, risks, and ho...
A tiny AI-focused microcap has surged 4,000% this year while staying under $1, drawing renewed interest from retail t...
A leading analyst signals more upside for CVS Health as Medicare-related momentum builds. Learn the key drivers, risk...
Palantir shares cooled in late June as investors weigh AI-led growth against valuation. Analysts remain divided, with...
Microsoft stock remains volatile in mid-2026 as AI momentum collides with rising capex and a securities suit. Yet the...
A mid-size fund reduced its TriMas stake by about $5 million after a strong run, but didn’t exit the position entirel...
Cathie Wood is famous for spotting disruptive growth. This guide breaks down what cathie wood goes bargain means and ...
March brings continued AI momentum, and two heavyweight names lead the charge: Nvidia and TSM. This article compares ...
Curious about SoundHound AI's future? This in-depth guide lays out five-year scenarios, key drivers, and concrete tip...
Chipotle stock could see meaningful upside as management advances a multi-year expansion plan and digital push, even ...
SSR Mining just sold its Copler Mine stake for $1.5 billion. This move reshapes its balance sheet, shifts portfolio r...
A quiet quantum player is showing real-world traction while the hype focuses on the big names. This analysis reveals ...